Search - tctmd.com

Displaying 101 - 120 of 211

Sort: Relevancy | Date

News

LGBTQ+ People at Risk of Worse CV Health, Subpar Care: AHA

Caitlin E. Cox

June 24, 2022

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Caitlin E. Cox

June 10, 2022

News Daily News

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

L.A. McKeown

June 06, 2022

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

News Daily News

NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes

L.A. McKeown

May 03, 2022

News Daily News

MOSAIC: Home Intervention Boosts Walking Time in PAD Patients

L.A. McKeown

April 15, 2022

News Daily News

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

L.A. McKeown

March 17, 2022

News Daily News

Fewer Diabetic Complications Seen When NOACs Given for AF

L.A. McKeown

February 22, 2022

News Daily News

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Caitlin E. Cox

February 11, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

Todd Neale

January 11, 2022

News Opinion CV Team Dispatch

January 2022 News Roundup

L.A. McKeown

January 01, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

Caitlin E. Cox

December 29, 2021

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Todd Neale

December 27, 2021

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

L.A. McKeown

December 20, 2021

Advertisement

LGBTQ+ People at Risk of Worse CV Health, Subpar Care: AHA

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

Omega-3 Fatty Acids Linked to BP Reductions, Meta-analysis Hints

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

June 2022 News Roundup

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes

MOSAIC: Home Intervention Boosts Walking Time in PAD Patients

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

Fewer Diabetic Complications Seen When NOACs Given for AF

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

January 2022 News Roundup

TCTMD’s Top 10 Most Popular Stories for December 2021

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content